BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 30423552)

  • 1. The Impact of Midodrine on Outcomes in Patients with Intradialytic Hypotension.
    Brunelli SM; Cohen DE; Marlowe G; Van Wyck D
    Am J Nephrol; 2018; 48(5):381-388. PubMed ID: 30423552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intradialytic hypotension: is midodrine beneficial in symptomatic hemodialysis patients?
    Cruz DN; Mahnensmith RL; Perazella MA
    Am J Kidney Dis; 1997 Dec; 30(6):772-9. PubMed ID: 9398120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midodrine is effective and safe therapy for intradialytic hypotension over 8 months of follow-up.
    Cruz DN; Mahnensmith RL; Brickel HM; Perazella MA
    Clin Nephrol; 1998 Aug; 50(2):101-7. PubMed ID: 9725781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Midodrine and cool dialysate are effective therapies for symptomatic intradialytic hypotension.
    Cruz DN; Mahnensmith RL; Brickel HM; Perazella MA
    Am J Kidney Dis; 1999 May; 33(5):920-6. PubMed ID: 10213650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intradialytic hypotension and risk of cardiovascular disease.
    Stefánsson BV; Brunelli SM; Cabrera C; Rosenbaum D; Anum E; Ramakrishnan K; Jensen DE; Stålhammar NO
    Clin J Am Soc Nephrol; 2014 Dec; 9(12):2124-32. PubMed ID: 25376764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midodrine treatment in a patient with treprostinil-induced hypotension receiving hemodialysis.
    Drambarean B; Bielnicka P; Alobaidi A
    Am J Health Syst Pharm; 2019 Jan; 76(1):13-16. PubMed ID: 31381098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of drugs on intradialytic hypotension: Antihypertensives and vasoconstrictors.
    Chang TI
    Semin Dial; 2017 Nov; 30(6):532-536. PubMed ID: 28681510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midodrine treatment for patients with hemodialysis hypotension.
    Flynn JJ; Mitchell MC; Caruso FS; McElligott MA
    Clin Nephrol; 1996 Apr; 45(4):261-7. PubMed ID: 8861803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertonic Mannitol for the Prevention of Intradialytic Hypotension: A Randomized Controlled Trial.
    Mc Causland FR; Claggett B; Sabbisetti VS; Jarolim P; Waikar SS
    Am J Kidney Dis; 2019 Oct; 74(4):483-490. PubMed ID: 31040088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Severe Intradialytic Hypotension With the Addition of High Dialysate Calcium Concentration to Midodrine and/or Cool Dialysate.
    Alappan R; Cruz D; Abu-Alfa AK; Mahnensmith R; Perazella MA
    Am J Kidney Dis; 2001 Feb; 37(2):294-9. PubMed ID: 11157369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Midodrine appears to be safe and effective for dialysis-induced hypotension: a systematic review.
    Prakash S; Garg AX; Heidenheim AP; House AA
    Nephrol Dial Transplant; 2004 Oct; 19(10):2553-8. PubMed ID: 15280522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamics in patients with intradialytic hypotension treated with cool dialysate or midodrine.
    Hoeben H; Abu-Alfa AK; Mahnensmith R; Perazella MA
    Am J Kidney Dis; 2002 Jan; 39(1):102-7. PubMed ID: 11774108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Midodrine for the treatment of intradialytic hypotension.
    Lim PS; Yang CC; Li HP; Lim YT; Yeh CH
    Nephron; 1997; 77(3):279-83. PubMed ID: 9375820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intradialytic Hypotension and Newly Recognized Peripheral Artery Disease in Patients Receiving Hemodialysis.
    Seong EY; Liu S; Song SH; Leeper NJ; Winkelmayer WC; Montez-Rath ME; Chang TI
    Am J Kidney Dis; 2021 May; 77(5):730-738. PubMed ID: 33316351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of frequent intradialytic hypotension with the clinical outcomes of patients on hemodialysis: a prospective cohort study.
    Wu Y; Lu J; Wang T; Zhu X; Xue J; You L
    Ren Fail; 2024 Dec; 46(1):2296612. PubMed ID: 38178566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretransplant Midodrine Use: A Newly Identified Risk Marker for Complications After Kidney Transplantation.
    Alhamad T; Brennan DC; Brifkani Z; Xiao H; Schnitzler MA; Dharnidharka VR; Axelrod D; Segev DL; Lentine KL
    Transplantation; 2016 May; 100(5):1086-93. PubMed ID: 26950718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric intradialytic hypotension: recommendations from the Pediatric Continuous Renal Replacement Therapy (PCRRT) Workgroup.
    Raina R; Lam S; Raheja H; Krishnappa V; Hothi D; Davenport A; Chand D; Kapur G; Schaefer F; Sethi SK; McCulloch M; Bagga A; Bunchman T; Warady BA
    Pediatr Nephrol; 2019 May; 34(5):925-941. PubMed ID: 30734850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midodrine efficacy and pharmacokinetics in a patient with recurrent intradialytic hypotension.
    Blowey DL; Balfe JW; Gupta I; Gajaria MM; Koren G
    Am J Kidney Dis; 1996 Jul; 28(1):132-6. PubMed ID: 8712208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fludrocortisone Is Associated With a Higher Risk of All-Cause Hospitalizations Compared With Midodrine in Patients With Orthostatic Hypotension.
    Grijalva CG; Biaggioni I; Griffin MR; Shibao CA
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29025750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of Iron Sucrose and Intradialytic Blood Pressure.
    Singh AT; Yen TE; Mothi SS; Waikar SS; Mc Causland FR
    Am J Kidney Dis; 2023 Jun; 81(6):647-654. PubMed ID: 36587889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.